Title |
Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease
|
---|---|
Published in |
PLOS ONE, September 2011
|
DOI | 10.1371/journal.pone.0025788 |
Pubmed ID | |
Authors |
Naoki Yahata, Masashi Asai, Shiho Kitaoka, Kazutoshi Takahashi, Isao Asaka, Hiroyuki Hioki, Takeshi Kaneko, Kei Maruyama, Takaomi C. Saido, Tatsutoshi Nakahata, Takashi Asada, Shinya Yamanaka, Nobuhisa Iwata, Haruhisa Inoue |
Abstract |
Alzheimer's disease (AD) is a neurodegenerative disorder that causes progressive memory and cognitive decline during middle to late adult life. The AD brain is characterized by deposition of amyloid β peptide (Aβ), which is produced from amyloid precursor protein by β- and γ-secretase (presenilin complex)-mediated sequential cleavage. Induced pluripotent stem (iPS) cells potentially provide an opportunity to generate a human cell-based model of AD that would be crucial for drug discovery as well as for investigating mechanisms of the disease. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 50% |
Chile | 1 | 25% |
Canada | 1 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 75% |
Scientists | 1 | 25% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 4 | 2% |
Spain | 2 | <1% |
Japan | 2 | <1% |
Brazil | 1 | <1% |
Singapore | 1 | <1% |
Korea, Republic of | 1 | <1% |
Denmark | 1 | <1% |
Hungary | 1 | <1% |
Argentina | 1 | <1% |
Other | 1 | <1% |
Unknown | 251 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 51 | 19% |
Student > Ph. D. Student | 49 | 18% |
Student > Master | 40 | 15% |
Student > Bachelor | 31 | 12% |
Student > Postgraduate | 15 | 6% |
Other | 53 | 20% |
Unknown | 27 | 10% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 92 | 35% |
Medicine and Dentistry | 37 | 14% |
Biochemistry, Genetics and Molecular Biology | 35 | 13% |
Neuroscience | 35 | 13% |
Engineering | 8 | 3% |
Other | 20 | 8% |
Unknown | 39 | 15% |